Elbeltagytherapeutics

Elbeltagy Therapeutics Co. is a biotechnology startup headquartered in Mansoura, Egypt, dedicated to advancing regenerative medicine. The company focuses on the utilization of dental-derived mesenchymal stem cells (MSCs) and engineered extracellular vesicles (EVs), maintaining a strong emphasis on clinical translation. In collaboration with the Healthcare Professionals Network for Egypt (HPNE), the company is working to establish a prototype Dental Pulp Stem Cell (DPSC) biobank in Egypt, designed to facilitate the isolation, preservation, and distribution of high-quality stem cells and EVs for research and future medical applications.

This initiative aims to create a Good Manufacturing Practice (GMP)-ready infrastructure that functions as a national and regional reference center, positioning Egypt within the global regenerative medicine ecosystem. The organization's efforts are designed to support translational research and standardize biobanking practices. Beyond its primary research and development focus, the company also operates a cosmetic product line branded as EVOXIR. By aligning with international biobanking standards, Elbeltagy Therapeutics seeks to foster a sustainable and scalable model for regenerative medicine development in developing countries.